This is the authors' abstract. We don't add key points for this paper.
We respond to Rattanaumpawan et al. [1], who describe a potential association between a case of severe dengue hemorrhagic fever and TAK-003 (Qdenga). TAK-003 is a live-attenuated tetravalent dengue vaccine based on a dengue virus (DENV)-2 backbone, expressing premembrane (prM) and envelope (E) proteins from all four serotypes [2]. Detection of all four vaccine strains in the patient’s sample is not unexpected for a live-attenuated tetravalent vaccine and reflects postvaccination viraemia. We wish to address the interpretation of these findings.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tricou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: